Home LiteratureArticle Details
PMID: 17786640 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Review

LC-MS-based metabolomics in drug metabolism.

Drug metabolism reviews ·Vol. 39 ·No. 2-3 ·2007-00-00 ·Pages 581-97

Chen C, Gonzalez FJ, Idle JR

Abstract

Xenobiotic metabolism, a ubiquitous natural response to foreign compounds, elicits initiating signals for many pathophysiological events. Currently, most widely used techniques for identifying xenobiotic metabolites and metabolic pathways are empirical and largely based on in vitro incubation assays and in vivo radiotracing experiments. Recent work in our lab has shown that LC-MS-based metabolomic techniques are useful tools for xenobiotic metabolism research since multivariate data analysis in metabolomics can significantly rationalize the processes of xenobiotic metabolite identification and metabolic pathway analysis. In this review, the technological elements of LC-MS-based metabolomics for constructing high-quality datasets and conducting comprehensive data analysis are examined. Four novel approaches of using LC-MS-based metabolomic techniques in xenobiotic metabolism research are proposed and illustrated by case studies and proof-of-concept experiments, and the perspective on their application is further discussed.

MeSH Terms
Animals Animals, Genetically Modified Biotransformation Chromatography, Liquid Humans Mass Spectrometry Mice Pharmaceutical Preparations/chemistry,metabolism Polymorphism, Genetic/genetics,physiology Xenobiotics/metabolism
Chemicals
Pharmaceutical Preparations Xenobiotics
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chen Chi
Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Gonzalez Frank J
Idle Jeffrey R
References (52)
52 references, click to expand
  1. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.
    Drug Metab Dispos. 2006 Oct;34(10):1722-33 PMID: 16815965
  2. Drug metabolite identification: stable isotope methods.
    J Clin Pharmacol. 1986 Jul-Aug;26(6):427-34 PMID: 3734132
  3. Metabonomics: a platform for studying drug toxicity and gene function.
    Nat Rev Drug Discov. 2002 Feb;1(2):153-61 PMID: 12120097
  4. HMDB: the Human Metabolome Database.
    Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6 PMID: 17202168
  5. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.
    Nat Med. 2002 Dec;8(12):1439-44 PMID: 12447357
  6. Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone).
    J Pharmacol Exp Ther. 2006 Sep;318(3):1330-42 PMID: 16775196
  7. Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets.
    J Ind Microbiol Biotechnol. 2005 Jun;32(6):234-52 PMID: 15895265
  8. 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
    Drug Metab Dispos. 2006 Sep;34(9):1563-74 PMID: 16782768
  9. Plant metabolomics: towards biological function and mechanism.
    Trends Plant Sci. 2006 Oct;11(10):508-16 PMID: 16949327
  10. Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.
    Drug Metab Dispos. 1975 Sep-Oct;3(5):332-7 PMID: 241613
  11. High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics.
    Methods Mol Biol. 2007;358:159-74 PMID: 17035686
  12. A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse.
    Chem Res Toxicol. 2006 Jun;19(6):818-27 PMID: 16780361
  13. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Oncogene. 2006 Mar 13;25(11):1629-38 PMID: 16550163
  14. Application of chimeric mice with humanized liver for predictive ADME.
    Drug Metab Rev. 2007;39(1):145-57 PMID: 17364883
  15. A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.
    Chem Res Toxicol. 2007 Mar;20(3):531-42 PMID: 17279779
  16. Metabolism of debrisoquine sulphate in rat, dog and man.
    Xenobiotica. 1976 Jul;6(7):405-9 PMID: 997588
  17. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?
    Philos Trans R Soc Lond B Biol Sci. 2006 Jan 29;361(1465):147-61 PMID: 16553314
  18. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.
    Nature. 1988 Feb 4;331(6155):442-6 PMID: 3123997
  19. Normalization method for metabolomics data using optimal selection of multiple internal standards.
    BMC Bioinformatics. 2007;8:93 PMID: 17362505
  20. Metabolite profiling: from diagnostics to systems biology.
    Nat Rev Mol Cell Biol. 2004 Sep;5(9):763-9 PMID: 15340383
  21. Cytochrome P450 and xenobiotic receptor humanized mice.
    Annu Rev Pharmacol Toxicol. 2006;46:41-64 PMID: 16402898
  22. Pharmaco-metabonomic phenotyping and personalized drug treatment.
    Nature. 2006 Apr 20;440(7087):1073-7 PMID: 16625200
  23. 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans.
    Drug Metab Dispos. 1998 Nov;26(11):1096-101 PMID: 9806952
  24. When good drugs go bad.
    Nature. 2007 Apr 26;446(7139):975-7 PMID: 17460642
  25. The fate of acetanilide in man.
    J Pharmacol Exp Ther. 1948 Sep;94(1):29-38 PMID: 18885611
  26. Pharmacogenomics: translating functional genomics into rational therapeutics.
    Science. 1999 Oct 15;286(5439):487-91 PMID: 10521338
  27. Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.
    Pharmacogenomics. 2006 Oct;7(7):1055-75 PMID: 17054416
  28. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies.
    J Proteome Res. 2005 Mar-Apr;4(2):591-8 PMID: 15822939
  29. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism.
    Nat Rev Drug Discov. 2003 Aug;2(8):668-76 PMID: 12904817
  30. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics.
    Anal Bioanal Chem. 2007 Jan;387(2):525-7 PMID: 16955259
  31. Computational prediction of human drug metabolism.
    Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):303-24 PMID: 16922645
  32. The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases.
    Biochem Pharmacol. 2007 Feb 15;73(4):561-73 PMID: 17123469
  33. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis.
    Rapid Commun Mass Spectrom. 2005;19(18):2659-70 PMID: 16124034
  34. Hypotensive response to debrisoquine and hydroxylation phenotype.
    Life Sci. 1978 Mar;22(11):979-83 PMID: 642709
  35. Role of gene knockout and transgenic mice in the study of xenobiotic metabolism.
    Drug Metab Rev. 2003 Nov;35(4):319-35 PMID: 14705864
  36. Data processing for mass spectrometry-based metabolomics.
    J Chromatogr A. 2007 Jul 27;1158(1-2):318-28 PMID: 17466315
  37. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids.
    Rapid Commun Mass Spectrom. 2003;17(23):2632-8 PMID: 14648901
  38. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.
    Cancer Res. 2000 Dec 15;60(24):6921-6 PMID: 11156391
  39. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
    Drug Metab Dispos. 1993 May-Jun;21(3):403-9 PMID: 8100494
  40. Polymorphic hydroxylation of Debrisoquine in man.
    Lancet. 1977 Sep 17;2(8038):584-6 PMID: 71400
  41. Cytochrome P450 humanised mice.
    Hum Genomics. 2004 May;1(4):300-6 PMID: 15588489
  42. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
    J Biol Chem. 2003 Apr 11;278(15):13480-6 PMID: 12566435
  43. Stable isotope labeling of Arabidopsis thaliana for an NMR-based metabolomics approach.
    Plant Cell Physiol. 2004 Aug;45(8):1099-104 PMID: 15356336
  44. Drug metabolism and drug interactions: application and clinical value of in vitro models.
    Curr Drug Metab. 2003 Oct;4(5):423-59 PMID: 14529374
  45. Achievement of a 920-MHz high resolution NMR.
    J Magn Reson. 2002 Jun;156(2):318-21 PMID: 12165269
  46. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
    Trends Pharmacol Sci. 2006 Nov;27(11):580-6 PMID: 17005258
  47. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.
    Chem Res Toxicol. 2001 Jun;14(6):611-50 PMID: 11409933
  48. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.
    J Proteome Res. 2007 Feb;6(2):459-68 PMID: 17269703
  49. Chemometrics in metabonomics.
    J Proteome Res. 2007 Feb;6(2):469-79 PMID: 17269704
  50. Mass spectrometry-based metabolomics.
    Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78 PMID: 16921475
  51. Near completely humanized liver in mice shows human-type metabolic responses to drugs.
    Am J Pathol. 2004 Sep;165(3):901-12 PMID: 15331414
  52. The metabolism of [14C]-debrisoquine in man.
    Br J Clin Pharmacol. 1979 Mar;7(3):257-66 PMID: 371651
Article Info
Journal
Drug metabolism reviews
Abbr.
Drug Metab Rev
ISSN
0360-2532
Published
2007-00-00
Pages
581-97
Language
English
Region
England
NLM ID
0322067
PMCID
PMC2140249
Subset
IM
Grants
Intramural NIH HHS · Z01 BC005562-19 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com